The study aimed to determine if acute phase proteins (APP) are markers of frailty in 2 old rats. We evaluated in male Wistar rats at 96 weeks of age (n=72) whether single 3 measurements of α 2 -macroglobulin, fibrinogen and albumin are predictive of mortality, body 4
n .
Introduction 18
Frailty syndrome is a physiological state of susceptibility that places older individuals 19 at high risk for adverse outcomes such as falls, disability, morbidity and institutionalization 20 (Dayhoff et al., 1998; Fried et al., 2001; Ferrucci et al., 2002a; Walston, 2004) . Frailty 21 ultimately leads to death. Frailty consists of multi-system decline and is considered to be a 22 consequence of changes in neuromuscular, endocrine and immune functions that occur as 23 people progress in age (Ferrucci et al., 2002a; Walston, 2004) . Frailty can and does result in 24 several "vicious loops" : neuromuscular impairment induces increased rate of falls and 25 fractures in old age; the act of falling causes itself hospitalisation and immobilisation, which 26 aggravates sarcopenia; sarcopenia leads to deficit in continuous neuromuscular training which 1 brings about neuromuscular impairment (Muhlberg and Sieber, 2004; Walston, 2004) . 2
Moreover, frailty has nutritional and metabolic implications which have themselves 3 deleterious implications (Chevalier et al., 2003; Muhlberg and Sieber, 2004; Puts et al., 2005) . 4
Early screening of frailty in the elderly population is essential to reduce the adverse 5 outcomes described above . Despite the growing awareness of this problem over the past two 6 decades, there is no clear guidelines for identifying and d escribing older adults as frail 7 (Markle-Reid and Browne, 2003; Walston, 2004) . Screening for frailty syndrome in humans 8 is often based on the measurement of parameters related to mobility and motor performance. 9
These include weakness (grip strength), weight loss, fatigue, slow walking speed and low 10 levels of physical activity (Fried et al., 2001 ). Subjects meeting three or more of these criteria 11 are categorized as frail (Fried et al., 2001) . Several researchers have sought to find sensitive 12 biomarkers of frailty (Ferrucci et al., 2002a) . Among the candidate bio markers are 13 compounds associated with the inflammatory process (Ferrucci et al., 2002a; De Martinis et 14 al., 2006) . Frail subjects have evidence of increased inflammation (Leng et al., 2002; Puts et 15 al., 2005) . Increased levels of certain acute phase reactants, including C-reactive protein 16 (CRP), clotting factors such as fibrinogen and factor VIII, and decrea sed level of albumin, 17 were associated with increasing frailty level in elderly (Walston et al., 2002) . In accordance, 18 the levels of inflammatory markers, such as interleukin-6 (IL-6) and CRP, increase with 19 ageing, and that elevated levels are associated with disability and mortality (Harris et al., 20 1999; Ferrucci et al., 2002b; Cohen et al., 2003; Bautmans et al., 2005) . 21
In spite of the fact that rat is a common model for human nutritional and metabolic 22 studies, to our knowledge, no investigation has assessed frailty in old rats. Frail rats are 23 expected to exhibit the human frailty phenotype, including vulnerability to mortality, body 24 weight loss and inflammation. Physical performance which is classically assessed in human 25 clinical settings cannot be easily evaluated in old rats. So, there is a need to identify plasma 26 ACCEPTED MANUSCRIPT 4 biomarkers of rat frailty. Measurements of inflammatory markers , that correlate with frailty, 1 has recently been proposed for identification of frail animals (Walston et al., 2006) . In the 2 present study, we investigated whether acute phase proteins (APP) are potential biomarkers of 3 frailty in old rats. 4
The APP α 1 -acid glycoprotein, α 2 -macroglobulin and fibrinogen are known to 5 increase with inflammation in rats (Fuller, G. M., 1993; Roberts, R. C., 1993; Breuillé et al., 6 1998; Ruot et al., 2002) . CRP is commonly used as a marker of inflammation in human 7 clinical trials and research settings (Kushner, I. and Maciewicz, A., 1993) . But CRP is a poor 8 marker of inflammation compared to fibrinogen in the rat (Giffen et al., 2003) . By contrast, 9 α 2 -macroglobulin in rats is an APP characterized by a kinetic relatively similar to human CRP 10 kinetic since both of them peak very quickly after inflammatory stress and thus α 2 -11 macroglobulin is a good marker of inflammation in the rat. The APP albumin is known to 12 decline with inflammation in rats (Aldred, A. R. and Schreiber, G., 1993; Breuillé et al., 1998; 13 Ruot et al., 2002) . We have recently shown that α 2 -macroglobulin and fibrinogen 14 concentrations were higher and albumin concentration was lower in old rats (95 week-old) 15 compared to adults (35 week-old), whereas plasma α1-acid glycoprotein concentration was 16 similar in both groups (Papet et al., 2003) . In addition, greater variability was observed in the 17 APP in the old rats compared to their adult rats counterparts. Taken together, α 2-18 macroglobulin, fibrinogen and albumin are potential candidates for assessing frailty in old 19 rats. 20
The purpose of the study was to determine if the APP, α 2 -macroglobulin, fibrinogen 21 and albumin, are biomarkers of frailty in old rats. The parameters assessed included mortality, 22 body weight loss and persistent inflammatory status evaluated in a 10-week longitudinal study 23 on a cohort of 96-week old rats. Inflammatory status was assessed by measuring the APP 24 throughout the follow -up period and IL-6, tumor necrosis factor-a (TNF-a), soluble TNF-a 25 receptor-1 (sTNFR-1) and lipopolysaccharide binding protein (LBP) at the end of the study. 26
Materials and methods 2

Animals 3
Male Wistar rats were produced and bred in our conventional (not specific -pathogen-free) 4 animal facility (Unité Expérimentale de Nutrition Comparée, INRA, Saint -Genès-5
Champanelle, France). They were maintained in collective cages (3 to 4 rats per cage) under 6 controlled conditions (temperature 21°C, relative humidity 55 %, 12-h light/dark cycles with 7 free access to water and standard pelleted food (A04 from SAFE (Scientific Animal Food and 8 Engineering), Villemoisson-sur -orge, France). The composition of the diet was 16 % protein, 9 3% fat, 60 % carbohydrates, 12 % water, fibers, vitamins and minerals. The study was 10 performed according to the current legislation on animal experiments in France. 11
Experimental design 12
The experimental cohort consisted of 119 rats at the age of 13 weeks, born over a two-13 week period. Blood samples were wit hdrawn from the lateral vein of 32 rats at 35 week-old in 14 order to estimate the adult cohort values for plasma levels of the three APP: α 2 -15 macroglobulin, fibrinogen and albumin. The longitudinal study was initiated when the rats 16 were 96 week-old (n = 72) and lasted for an additional 10 weeks. Body weight was measured 17 at weeks 96 and 106 and sample collection from a lateral tail vein was performed at weeks 96, 18 100, 104 and 106. Mortality was recorded weekly. Samples collected throughout the study 19 were assayed for α 2 -macroglobulin, fibrinogen and albumin. Additionally, samples collected 20 at 106 weeks of age were also assayed for IL-6, TNF-a, sTNFR-1 and LBP. All samples were 21 stored at -80°C until subjected to analyses. 22
Acute-phase protein concentrations 23
Plasma fibrinogen level was measured by turbidimetry (Macart et al., 1989) 
on a 24
Cobas Mira analyzer (ABX Diagnostics, Montpellier, France). Concentration is expressed as 25 g human equivalent/L since human fibrinogen was used as reference (Ingen, Rungis, France) . 26
Plasma levels of α 2 -macroglobulin and albumin were measured by single radial 1 immunodiffusion (Breuillé et al., 1998) . Serum concentration of LBP was measured by 2 Enzyme Linked ImmunoSorbent Assay (ELISA) that detects free LBP (Biometec, 3 Greifswald, Germany); its detection limit was 5 ng/mL. 4
Serum levels of cytokines and cytokine receptor 5
Serum levels of IL-6, TNF-a and sTNFR-1 were quantified with specific ELISA kits 6 (R6000B, RTA00 and MRT10, respectively, R &D Systems, Abingdon, UK). All 7 quantifications were realized according to the manufacturer. Detection limits were 21, 12 and 8 16 pg/mL for IL-6, TNF-a and sTNFR-1, respectively. All samples and standards were 9 measured in duplicate and the means were used in statistical analyses. 10
Statistical analysis 11
All v alues are given as means ± SD. Statistical analyses were performed using 12
StatView for Windows, version 5 software (SAS Institute, Cary, NC). Values of P < 0.05 are 13 considered significant for all analyses. 14 The effect of age was analyzed using one-way ANOVA and Fisher's PLSD test and 15 Student's t test for unpaired data was used to compare alive and dead old rats. Linear 16 regression was used to determine the relationship among APP themselves and between the 17 percentage of body weight change and each APP. 18
Several statistical tests were used to analyse mortality data obtained for all rats (n = 19 72). Rats were divided into quartile categories of either α 2 -macroglobulin, fibrinogen or 20 albumin plasma levels at the age of 96 weeks. Survival curves were generated by the Kaplan-21
Meier method and compared by the log-rank test in order to analyze the impact of APP 22 plasma levels measured in 96 week-old rats on mortality across the 10 weeks of follow-up. 23
The relative risk of death was calculated using the Cox proportional hazards model for 24 categoric al variables. Univariate Cox and multivariate Cox regressions for continuous 25 variables were used to analyze how APP were predictive of mortality. 26
Changes in APP during the follow -up period and the values of sTNFR-1 and LBP at 1 the age of 106 weeks were analyzed on rats which were still alive at 106 weeks (n = 48). For 2 each APP, data from alive rats from quartiles 1 and 2 (bottom half) were compared to those of 3 alive rats from quartiles 3 and 4 (top half). Two-way ANOVA for repeated measurements 4 with group as the between-rat factor and time as the within -rat factor was performed to 5 analyze APP changes. When significant effects were observed for group and time, Fisher's 6 PLSD test and Student's t test for unpaired data were performed as post ANOVA tests. 7
Student's t test for unpaired data was also used to analyze the group effect for sTNFR-1 and 8 LBP at the age of 106 weeks. 9 10 3. Results 11
Rat characteristics 12
The three APP, α 2 -macroglobulin, fibrinogen and albumin, and body weight were 13 significantly affected by age (Table 1) . α 2 -macroglobulin and fibrinogen plasma levels were 14 higher and albumin plasma level lower at the age of 96 and 106 weeks than at the age of 35 15 weeks. In 96 week-old rats, α 2 -macroglobulin and fibrinogen were highly positively 16 correlated to each other (r = 0.73, P < 0.001, n = 72) and each of them was negatively 17 correlated with albumin (r = -0.71 and -0.67, respectively, P < 0.001, n = 72). Mean body 18 weight was higher in 96 week-old rats than in 35 week-old rats. At 96 weeks of age, rat body 19 weight was negatively correlated with α2-macroglobulin and fibrinogen (r = -0.46 and -0.29, 20 respectively, P < 0.05, n = 72) and was positively correlated with albumin (r = 0.46, P < 21 0.001, n = 72). 22
APP measurements at 96 weeks of age are predictive of the mortality 23
Between 96 and 106 weeks of age, 24 rats died which represent ed a 33 % of mortality 24 rate. The rats that died prior to 106 weeks had higher α 2 -macroglobulin (851 %) and 25
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8 fibrinogen (47 %) and lower albumin (24 %) plasma levels than alive rats (Table 2) . In 1 addition, the mean body weight of deceased rats was 12 % lower than their alive counterparts. 2 Kaplan-Meier analyses show that each APP measured at 96 weeks of age was 3 associated with 10-week mortality (Figure 1) . α 2 -macroglobulin plasma level in the top 4 quartile (≥ 506 mg/L) was the strongest predictor of mortality (relative risk = 11.6; 95 % 5 confidence interval (CI) = 4.8 to 27.7; P < 0.0001). Rats belonging to the top fibrinogen 6 quartile had an 8.1-fold higher risk of mortality (95 % CI = 3.5 to 18.8; P < 0.0001) than 7 those of the other quartiles ( < 5.4 g/L). The mortality risk of rats in the bottom albumin 8 quartile (≤ 10 g/L) relative to the three other quartiles was 5.3 (95 % CI = 2.3 to 11.9; P < 9 0.0001). Univariate Cox analyses show that each of the three APP measured at the age of 96 10 weeks was predictive of mortality. The multivariable Cox regression model using forward 11 stepwise selection method conducted with the three APP show that α 2 -macroglobulin alone 12 was sufficient to explain rat mortality during the 10-week follow -up. 13
APP levels at 96 weeks of age and body weight change 14
Percentage of body weight loss throughout 10-week follow -up in rats alive at 106 15 weeks (n = 48) was negatively correlated with α 2 -macroglobulin levels measured at 96 weeks 16 old (P < 0.01) ( Table 3) . A similar correlation with fibrinogen level was observed, but did not 17 attain statistical significance (P = 0.08) . However, no associations between body weight 18 changes and albumin levels were observed. 19
APP levels at 96 weeks of age and inflammatory status throughout 10 -week follow-up 20
To determine if single measurements of APP were predictive of the consecutive 21 inflammatory status, changes in the APP thr oughout the follow -up period and values of other 22 inflammatory markers at 106 weeks of age were assessed in surviving rats. This analysis was 23 performed on the top half and the bottom half groups constituted on the basis of each plasma 24 APP measured in all rats at 96 weeks of age (Table 4) . Rats with α 2 -macroglobulin levels > 25 ACCEPTED MANUSCRIPT 9 91 mg/L at 96 weeks of age exhibited higher levels of plasma α 2 -macroglobulin (~ 450 %) 1 and fibrinogen (~ 34 %) and lower levels of plasma albumin (~ 20 %) at all tested times 2 during the follow -up period than the other rats, excepted for albumin at the age of 96 weeks. 3
Interestingly ser um sTNFR-1, detected in all rats at the age of 106 weeks, had a 66 % higher 4 level in rats having the highest α 2 -macroglobulin level. No difference was observed in levels 5 of serum LBP. No detectable level of serum IL -6 and TNF-a was observed. Rats with 6 fibrinogen levels > 4 g/L at 96 weeks of age exhibited higher levels of plasma α2-7 macroglobulin (~ 280 %) and fibrinogen (~ 47 %) and lower levels of plasma albumin (~ 17 8 %) at all tested times during the follow -up than other rats, excepted for albumin at the age of 9 96 weeks and for α2-macroglobulin at the age of 100 weeks. The levels of both serum 10 sTNFR-1 and LBP at the age of 106 weeks were higher in rats having the highest fibrinogen 11 level (70 and 130 % , respectively). Rats with albumin levels lower than 12 g/L at 96 weeks of 12 age exhibited similar values for the three APP throughout 10-week period (except albumin at 13 the age of 96 weeks) and similar levels of sTNFR-1 and LBP at the age of 106 weeks than 14 other rats. 15 16
Discussion 17
In this paper, we report that highest plasma levels of α 2 -macroglobulin, fibrinogen and 18 lowest albumin are predictive of mortality. According to body weight loss and persistent 19 inflammatory status, moderate levels of α 2 -macroglobulin and fibrinogen are biomarkers of 20 frailty in old rats , with α 2 -macroglobulin being slightly more powerful than fibrinogen. 21
Regardless of the type of statistical analysis performed, α 2 -macroglobulin, fibrinogen 22 and albumin measured in 96 week-old rats were associated with 10-week mortality. Rats that 23 died during the 10-week follow-up had higher concentrations of α2-macroglobulin and 24 fibrinogen, and lower concentration of albumin (Student's t test). Kaplan and univariate Cox 25 analyses were significant for each APP. The multivariate Cox regression model showed that 1 α 2 -macroglobulin alone was sufficient, likely due to the fact that the three APP are correlated 2 to each other. This is in agreement with the highest log rank test for α 2 -macroglobulin alone. 3
The mortality was significantly enhanced in rats exhibiting extremely high 4 concentrations of α 2 -macroglobulin (506 to 3390 mg/L) and fibrinogen (5.4 to 10.6 g/L), and 5 extremely low concentrations of albumin (10 to 4 g/L). These values correspond to those 6 observed during acute inflammation, such as sepsis (Breuillé et al., 1998; Breuillé et al., 1999; 7 Ruot et al., 2002) . In addition, these rats had the lowest body weight. This inflammation could 8 be due to aging per se; however, age -associated inflammation in humans is a muc h lower 9 grade inflammation (Bruunsgaard and Pedersen, 2003) . These rats may have been infected by 10 chronic pathogen since they were bred in none specific -pathogen-free animal facility. 11
Moreover, these rats may have had some acute or chronic illness that activated inflammatory 12 pathways such as chronic nephropathy, cardiomyopathy, and neoplasia which are the major 13 age-related pathologies in rats (Maeda et al., 1985) . Unfortunately, no data were collected on 14 any illnesses and death causes in the present study. Even if the etiology of this inflammation 15 is not known, it definitively enhanced mortality rate. It has been shown in elderly that an 16 increase in CRP level, corresponding to either the third tertile or the fourth quartile in most 17 human studies, was associated with increased risk of mortality (Harris et al., 1999; Reuben et 18 al., 2002; Tice et al., 2003; Kritchevsky et al., 2005) . In a recent meta-analysis, the age-19 adjusted relative risk per 1 g/L increase in usual fibrinogen level was 2.06-2.76 for cardio-20 vascular disease mortality and 2.03 for nonvascular mortality in healthy middle -aged adults 21 (Danesh et al., 2005) . In addition, lowest albumin levels were associated with an increased 22 mortality risk in community-dwelling elderly subjects (Corti et al., 1994; Sahyoun et al., 23 1996; Reuben et al., 2002) . Altogether, our results obtained in rats are in line with data known 24 in humans and give a prognostic value of some acute phase proteins in regards to mortality. 25 Body weight loss is both a characteristic and an outcome of frailty in humans (Fried et 1 al., 2001 ). In the survivors of our cohort of rats, among the three APP tested, only α 2 -2 macroglobulin was significantly associated with 10-week body weight loss. A similar trend 3 was observed for fibrinogen, but not with albumin. In the elderly, the influence of 4 inflammatory status on body weight loss has not been directly assessed, but acute 5 inflammation plays a major role in the pathophysiological of cachexia (Morley et al., 2006) . 6
Albumin decreases in inflammatory and malnutrition states (Don and Kaysen, 2004) . 7
Considering that old rats, which died were the one s that lost the most weight, it is surpr ising 8 that low level of albumin was only associated with high mortality but not with body weight 9 loss. This questions the validity of albumin as a nutritional marker in old rats. Unfortunately, 10 measurement of food intake or other nutritional markers were not assessed in this study. 11
Single measurements of α 2 -macroglobulin and fibrinogen, but not albumin, were 12 predictive of consecutive inflammatory status in survivors, assessed not only by these APP 13 but also with additional inflammatory markers, including LBP and sTNFR-1. Plasma level of 14 LBP , which is recognized as an APP (Tobias et al., 1986) , rises dramatically after 15 inflammatory challenges (infectious or not) (Gallay et al., 1994; Myc et al., 1997; Fenton and 16 Golenbock, 1998) . It was higher in old rats characterized as inflamed from repartitions based 17 on fibrinogen. It is well-known that TNF-α plays an important pathophysiological role in a 18 wide range of chronic disorders, but sTNFRs are stronger markers of severity and clinical 19 outcome than TNF-α itself (Aderka, 1996) and are essential for evaluation of the TNF system 20 (Ferrari et al., 1995) . Unfortunately, the pro-inflammatory cytokines TNF-α and IL-6 were 21 undetectable in the sera of our old rats, probably due to the low sensitivity of the ELISA. 22
Interestingly, sTNFR-1 levels were consistently higher in rats characterized as inflamed based 23 on α 2 -macroglobulin or fibrinogen levels. Inflammatory status in old rats, assessed with α 2 -24 macroglobulin or fibrinogen was not transient but persistent for at least 10 weeks. 25 Accordingly, it has been shown in a human study that CRP values appear relatively tightly 1 regulated over a 6-month period (Macy et al., 1997) . 2
In the present study, moderate α 2 -macroglobulin and fibrinogen levels in old rats was 3 clearly associated with worsening of body weight loss and persistent inflammation, which are 4 strong criteria of frailty in humans . The etiology of this moderate inflammation is not known, 5 it could be either associated to age per se or to subclinical diseases (Grimble, 2003) . In this 6
regard, a recent paper shows an association between chronic asymptomatic infection, 7 inflammation and frailty in elderly (Schmaltz et al., 2005) . Even if rats exhibiting moderate 8 inflammation were not at high risk of mortality during the 10-week follow-up, it is not 9 excluded that they would be in a longer follow -up study. Hence, moderate α 2 -macroglobulin 10 and fibrinogen levels can be considered as markers of frailty in old rats. 11
Taken together, the results presented here demonstrate that the highest levels of α 2 -12 macroglobulin and fibrinogen and the lowest levels of albumin are predictive of mortality, 13 whereas, moderate levels of α 2 -macroglobulin and fibrinogen are biomarkers of frailty in old 14 rat (as evaluated by body weight loss and persistent inflammatory status ). These data are 15 consistent with a human study showing that eleva ted levels of CRP (> 5.5 mg/L) or fibrinogen 16 (> 3.9 g/L) are associated with higher risks for prevalent frailty, the relation between CRP 17 levels and frailty being higher than that between fibrinogen levels and frailty (Walston et al., 18 2002) . Thus, in old rats α 2 -macroglobulin, as CRP in humans, is a more powerful biomarker 19 of frailty than fibrinogen. 20 (n = 32) (n = 72) (n = 48) Values are means ± SD. * P < 0.001, ** P < 0.0001 versus age -matched rats alive at 106 weeks (Student's t test for unpaired data). Linear regressions were performed between body weight change throughout the follow -up and plasma levels of each of the three APP measured at the age of 96 weeks in rats alive at 106 weeks (n = 48), r : Pearson correlation coefficient. APP levels at 96 weeks of age
